Related Experiment Video
Updated: May 23, 2026

Array Comparative Genomic Hybridization (Array CGH) for Detection of Genomic Copy Number Variants
Published on: February 21, 2015
Unique Combination of 22q11 and 14qter Microdeletion Syndromes Detected Using Oligonucleotide Array-CGH
E Zrnová1, V Vranová, J Soukalová
1Department of Genetics and Molecular Biology, Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
Insights
This study details a rare case of a child with both 22q11 deletion syndrome and 14q terminal deletion syndrome. Genetic analysis identified a complex translocation and deletions on chromosomes 14 and 22.
Area of Science:
- Genetics
- Human Biology
- Pediatrics
Background:
- 22q11 deletion syndrome is a common genetic disorder with variable clinical manifestations.
- 14q terminal deletion syndrome is a rare chromosomal abnormality associated with distinct facial features and developmental issues.
- Co-occurrence of multiple chromosomal abnormalities can complicate diagnosis and management.
Purpose of the Study:
- To report and characterize a unique case of a pediatric patient with a concurrent 22q11 deletion and 14q terminal deletion.
- To investigate the genetic basis and inheritance pattern of these combined chromosomal abnormalities.
- To correlate the genotype with the observed clinical phenotype.
Main Methods:
- Karyotyping using G-banding and fluorescence in situ hybridization (FISH).
- Comparative genomic hybridization on oligonucleotide-based microarray (array-CGH) for precise deletion mapping.
- Clinical examination and assessment of familial genetic status.
Main Results:
- The proband presented with features of 22q11 deletion syndrome but lacked typical immunodeficiency.
- Genetic analyses revealed a karyotype of 45,XY,der(14)t(14;22)(q32.3;q11.2),-22, with deletions at 22q11.21 (∼4.25 Mb) and 14q32.33qter (∼3.24 Mb).
- The mother carried a balanced translocation with a deleted 14q telomere and exhibited mild symptoms consistent with terminal 14q deletion syndrome.
Conclusions:
- This case highlights the possibility of co-occurring 22q11 deletion and 14q terminal deletion syndromes.
- Array-CGH is crucial for accurate diagnosis and delineation of complex chromosomal rearrangements.
- The study emphasizes the phenotypic variability within these syndromes and the importance of comprehensive genetic evaluation.
Abstract:
We report an infant with a unique combination of 22q11 deletion syndrome and 14q terminal deletion syndrome. The proband had clinical symptoms compatible with diagnosis of 22q11 deletion syndrome: microcephaly, micrognathia, high-arched palate, hypertelorism, short palpebral fissures, square nasal root, prominent tubular nose, hypoplastic nasal alae, bulbous nasal tip, dysplastic low-set ears, short philtrum, and heart defect, but no cell-mediated immunodeficiency typical for the syndrome. G-banding and fluorescence in situ hybridization analyses revealed a karyotype 45,XY,der(14)t(14;22)(q32.3;q11.2),-22.ish del(14)(q32.33)(D14S1420-),del(22)(q11.2q11.2)(N25-). Subsequent analyses disclosed a translocation between chromosomes 14 and 22 in the proband's mother with a deleted 14q telomere. Using comparative genome hybridization on oligonucleotide-based microarray (array-CGH), the deletion at 22q11.21 in the size of ∼4.25 Mb was revealed in the proband as well as the deletion of the telomeric area at 14q32.33qter (∼3.24 Mb) in the proband and his mother. However, both the proband and his mother showed mild symptoms (microcephaly, thin lips, carp-shaped mouth) typical for patients with the described terminal 14q deletion syndrome.
More Related Videos
09:30Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
Published on: August 17, 2022
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
Related Concept Videos
Karyotyping
Karyotyping
DNA Microarrays